<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xml:lang="en-us" lang="en-us">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
<meta name="copyright" content="(C) Copyright 2005"/>
<meta name="DC.rights.owner" content="(C) Copyright 2005"/>
<meta name="DC.Type" content="topic"/>
<meta name="DC.Title" content="Licensing and Intellectual Property"/>
<meta name="prodname" content="CDAR2L3_IG_EMSRUNRPT_DSTUR2"/>
<meta name="version" content="2013JUL"/>
<meta name="release" content="DSTUR2"/>
<meta name="brand" content="HL7 IG for CDA R2"/>
<meta name="platform" content="US Realm"/>
<meta name="series" content="Draft Standard for Trial Use"/>
<meta name="DC.Format" content="XHTML"/>
<meta name="DC.Identifier" content="topicId"/>
<meta name="DC.Language" content="en-us"/>
<link rel="stylesheet" type="text/css" href="../css/commonltr.css"/>
<title>Licensing and Intellectual Property</title>
</head>
<body id="topicId">
<div>
	<p><b>For Discussion and Demonstration Only</b> The Normative content for these specifications
	may be found on the HL7, IHE, and HITSP web sites.</p>
</div>

  <h1 class="title topictitle1">Licensing and Intellectual Property </h1>

  <div class="body">
    <p class="p"/>

    <p class="p"> Publication of this draft standard for trial use and comment has been approved by Health
      Level Seven International (HL7). This draft standard is not an accredited American National
      Standard. The comment period for use of this draft standard shall end 18 months from the date
      of publication. Suggestions for revision should be submitted at
      http://www.hl7.org/dstucomments/index.cfm.</p>

      
      <p class="p">Following this 18 month evaluation period, this draft standard, revised as necessary, will be 
      submitted to a normative ballot in preparation for approval by ANSI as an American National 
      Standard. Implementations of this draft standard shall be viable throughout the normative ballot 
      process and for up to six months after publication of the relevant normative standard. </p>

      
    <p class="p">Copyright © 2012
      Health Level Seven International ® ALL RIGHTS RESERVED. The reproduction of this material in
      any form is strictly forbidden without the written permission of the publisher. HL7
      International and Health Level Seven are registered trademarks of Health Level Seven
      International. Reg. U.S. Pat &amp;amp; TM Off.</p>

    <p class="p"/>

    <p class="p"> A.<strong class="ph b">If you are the individual that downloaded or ordered this HL7 Standard,
        specification or other work (in each and every instance "Material")</strong>, the following
      describes the permitted uses of the Material.  </p>

    <p class="p">B. <strong class="ph b">If you are NOT such individual,</strong> you are not authorized to make any use of
      the Material. To obtain an authorized copy of this Material, please visit
      http://www.hl7.org/implement/standards/index.cfm.  </p>

    <p class="p">C. <strong class="ph b">If you are not an HL7 Organizational Member</strong>, the following are your
      permitted uses of this Material:  </p>

    <p class="p">1. <strong class="ph b">Read and Copy License Only</strong>. HL7 hereby grants you the right, without
      charge, to download and copy (for personal use only) this Material for study purposes only.
      This license grant does not include the right to sublicense or modify the Material, or to
      implement the Material, either in whole in part, in any product or service.  Please see
      http://www.hl7.org/legal/ippolicy.cfm for the full license terms governing the Material.  </p>

    <p class="p">D. <strong class="ph b">If you are an HL7 Organizational Member</strong>, the following are your permitted
      uses of this Material.  </p>

    <p class="p">1. <strong class="ph b">Implementation License Terms</strong>.  </p>

    <p class="p">1.1 <strong class="ph b"> Definitions</strong>. As used in this Agreement, the following terms shall have the
      following definitions:  </p>

    <p class="p">"<strong class="ph b">Compliant Product</strong>" is a product or service that implements Material that is an HL7
      Specification in whole or in part.  </p>

    <p class="p">"<strong class="ph b">End User</strong>" is a company, entity or individual that is the ultimate purchaser or
      licensee from Licensee of a Compliant Product.  </p>

    <p class="p">1.2  <strong class="ph b">License</strong>. In consideration of becoming an Organizational member of HL7 and
      continuing to pay the appropriate HL7 Organizational membership fees in full, HL7 hereby
      grants to you without additional charge, on a perpetual (except as provided for in the full
      license terms governing the Material), non-exclusive and worldwide basis, the right to (a)
      download, copy (for internal purposes only) and share this Material with your employees and
      consultants for study purposes, and (b) utilize the Material for the purpose of developing,
      making, having made, using, marketing, importing, offering to sell or license, and selling or
      licensing, and to otherwise distribute, Compliant Products, in all cases subject to the
      conditions set forth in this Agreement and any relevant patent and other intellectual property
      rights of third parties (which may include members of HL7). No other license, sublicense, or
      other rights of any kind are granted under this Agreement.  </p>

    <p class="p">Please see http://www.hl7.org/legal/ippolicy.cfm for the full license terms governing the
      Material. </p>

  </div>


</body>
</html>